EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-SML179625MG
MFR#: SML1796-25MG
Atazanavir inhibits the cleavage of gag and gag-pol polyproteins in human immunodeficiency virus. It is absorbed and metabolized by cytochrome P450 present in the liver. It has minimal side effects and has no effect on insulin sensitivity and serum l
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Atazanavir >=98% (HPLC)
|
Atazanavir inhibits the cleavage of gag and gag-pol polyproteins in human immunodeficiency virus. It is absorbed and metabolized by cytochrome P450 present in the liver. It has minimal side effects and has no effect on insulin sensitivity and serum l | 3042-SML17965MG | EA | |
Atazanavir sulfate >=95% (HPLC)
|
Atazanavir sulfate >=95% (HPLC) | 3042-SML23085MG | EA | |
Atazanavir sulfate >=95% (HPLC)
|
Atazanavir sulfate >=95% (HPLC) | 3042-SML230825MG | EA | |
Atazanavir sulfate
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-1044334200MG | EA | |
Atazanavir Related Compound A
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-104435625MG | EA |